KAITLYNN HAFELI: Open Payments
NPI 1861258899 · HERMITAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $95 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $284 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Optinose US, Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $13 |
Products named: DUPIXENT, NEFFY, Xhance, Ryaltris, FASENRA, TEZSPIRE, XOLAIR.
Industry payments across TN — which companies pay providers there.
